| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Medical Officer
3 companies
Hannah Alison L. is a Director at NEOGENOMICS INC with holdings across 3 companies. Recent SEC Form 4 filings include 2 buys and 1 sell.
Estimated insider holdings value: $1.6M based on current market prices.